• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,220.85
  • -1.09 %
  • -$422.06
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Phoenix Biotech Acquisition Corp. (PBAXW) Stock Price, News & Analysis

Phoenix Biotech Acquisition Corp. (PBAXW) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.05
Day's range
$0.06
50-day range
$0.0137
Day's range
$0.09
  • Country: N/A
  • ISIN: N/A
52 wk range
$0.05
Day's range
$0.06
  • CEO: Mr. Christopher B. Ehrlich M.B.A.
  • Website: N/A
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -147,263.78
  • Piotroski Score 4.00
  • Grade N/A
  • Symbol (PBAXW)
  • Company Phoenix Biotech Acquisition Corp.
  • Price $0.06
  • Changes Percentage (-7.69%)
  • Change -$0.01
  • Day Low $0.05
  • Day High $0.06
  • Year High $0.06

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/30/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio 0
  • Forward P/E Ratio 0
  • P/E Growth 0
  • Net Income $-667,736

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Phoenix Biotech Acquisition Corp. Frequently Asked Questions

  • What is the Phoenix Biotech Acquisition Corp. stock price today?

    Today's price of Phoenix Biotech Acquisition Corp. is $0.06 — it has decreased by -7.69% in the past 24 hours. Watch Phoenix Biotech Acquisition Corp. stock price performance more closely on the chart.

  • Does Phoenix Biotech Acquisition Corp. release reports?

    Yes, you can track Phoenix Biotech Acquisition Corp.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Phoenix Biotech Acquisition Corp. stock forecast?

    Watch the Phoenix Biotech Acquisition Corp. chart and read a more detailed Phoenix Biotech Acquisition Corp. stock forecast to see what analysts suggest you do with its shares.

  • What is Phoenix Biotech Acquisition Corp. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Phoenix Biotech Acquisition Corp. stock ticker.

  • How to buy Phoenix Biotech Acquisition Corp. stocks?

    Like other stocks, PBAXW shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Phoenix Biotech Acquisition Corp.'s EBITDA?

    Phoenix Biotech Acquisition Corp. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Phoenix Biotech Acquisition Corp.’s financial statements.

  • What is the Phoenix Biotech Acquisition Corp.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -2.6203091461, which equates to approximately -262.03%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Phoenix Biotech Acquisition Corp. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Phoenix Biotech Acquisition Corp.'s financials relevant news, and technical analysis. Phoenix Biotech Acquisition Corp.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Phoenix Biotech Acquisition Corp. stock currently indicates a “sell” signal. For more insights, review Phoenix Biotech Acquisition Corp.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.